Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity
Federico Cavanna, Stephanie L. Muller, Laura Alethia de la Fuente, Federico Zamberlán, Matías Palmucci, Lucie Janeckova, Martin Kuchař, Carla Pallavicini, Enzo Tagliazucchi
This study investigates the effects of microdosing psilocybin mushrooms using a double-blind placebo-controlled design and finds that active doses produce more intense subjective effects, with mixed results on other measures.
bioRxiv · Nov 30, 2021 · PreprintNeuroscience